News

Gothenburg University, RISE and Iscaffpharma received the prestigious grant support and are partnering with AstraZeneca (LSE/STO/Nasdaq: AZN), for a project to develop synthetic 3D-models that [...]

Publication showing that cells cultured on patient-derived scaffolds closely resembled cells cultured on 3D printed scaffolds, contrasting 2D and Matrigel-cultured cells, regardless of a normoxic [...]

New publication showing how individual patient specific microenvironments influence the chemotherapy response in colorectal cancer. [...]

Published patent application for the use of patient derived scaffolds within immune-oncology The patent application covers the use of cell-free scaffolds  as a predictive tool in assessing cancer [...]

Iscaffpharma interviewed on the importance of human microenvironment for pre-clinical drug screening. Listen here

8.-3d-printed-nanocellulose-scaffolds-as-a-cancer-cell-culture-model-system

Alginate-based 3D printed scaffolds used as a model of patient derived breast cancer micro-environments in drug discovery. [...]

PDSs repopulated with cancer cells can be used to assess how cancer secretion is effected by specific and varying microenvironments. Read full article here See information video   [...]

Patient derived scaffolds from breast cancer used to create unique fingerprints showing the potential in-vivo effect of chemotherapy. http://Breast cancer patient-derived scaffolds as a tool to [...]